Intellectual Property India Publishes Patent Application for Next-Generation Wearable Non-Invasive Patch For Continuous Bilirubin And Vital Monitoring For Safe And Early Neonatal Care

MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202641071196 A) filed by Karpaga Vinayaga College Of Engineering & Technology; Dr. T. Sangeetha; Ms. R. Oviya; Ms. G. Kavya; Ms. P. M. Pavadharani; and Mr. M. Prathap on June 08, 2026, for Next-Generation Wearable Non-Invasive Patch For Continuous Bilirubin And Vital Monitoring For Safe And Early Neonatal Care.

Inventors include Dr. T. Sangeetha; Ms. R. Oviya; Ms. G. Kavya; Ms. P. M. Pavadharani; Mr. M. Prathap; Mr. Almarzuq; Mr. Hemachandran; Dr. B. Sathyamurthi; Dr. B. S. Tony; and Dr. Manigandan.

The application for the patent was published on June 19, 2026, under issue no. 25/2026.

Abstract: Worldwide, milder forms of neonatal jaundice are a frequent clinical challenge; it is estimated that 25-50% of term and up to 80% of preterm infants are at risk for or require treatment for hyperbilirubinemia in the first week of life, in India it is reported that almost 60% children could develop clinically significant jaundice Forming a major cause for admission amongst both rural and urban set-ups.Unrecognised, severe hyperbilirubin typically results in bilirubin-induced neurological dysfunction and kernicterus, which result in problematic massage is an important contributor to predicting chronic morbidity. However, such methods are mostly confined to intermittent sampling studies, which are invasive laborious and not practical in resource-poor settings. To bridge this gap, we propose a low-cost wearable neonatal patch that utilises the principle of a transcutaneous bilirubinometer and, along with the reasonable accuracy for measuring the oxygen saturation (sp02) (107), pulse rate (106), glucose levels (108), and heart rate( 109). And with the incorporation of wireless connectivity for providing real-time alerts to be received by healthcare staff and caregivers, thus enabling timely decision making, integrating multiple vital parameters into one device provides us a scalable solution for comprehensive neonate monitoring.This will reduce the reliance on extensive blood sampling, improve the efficacy of phototherapy management and in turn can lead to improved clinical outcomes in neonatal management especially in rural low-resource health setups.

Disclaimer: Curated by HT Syndication.